
News|Articles|January 2, 2005
- Pharmaceutical Technology-01-02-2005
- Volume 29
- Issue 1
The Pipeline Crisis
Committees make prudent decisions and avoid mistakes, but they're afraid of the new.
Advertisement
Articles in this issue
about 21 years ago
An Overview of the Effect of Moisture on Compaction and Compressionabout 21 years ago
The Outsourcing Advantages in Formulation Developmentabout 21 years ago
Drug Safety and Access Top Policy Concerns for 2005about 21 years ago
Comparison of EP "Heavy Metals" Test with USP "Conductivity" Testabout 21 years ago
Patheon Places Big Bet with Mova Acquisitionabout 21 years ago
January 2005about 21 years ago
In the Spotlight-January 2005Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 2: A Detailed Assessment for Specification Equivalence
4
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
5




